Statement - EPHA

Transparency is needed to reap the full benefits of the EU’s investment in its Vaccines Strategy, say health NGOs

by European Public Health Alliance | Sep 18, 2020 | COVID-19, Universal Access and Affordable Medicines | Latest Developments

The COVID-19 crisis represents an unprecedented challenge for societies in the European Union as well as at a global level. The European vaccines strategy’s Advance Purchase Agreements (APAs) mechanism has been used by the EU to procure vaccines for COVID-19. We...

MEPs vote for action on medicines shortages – what should be the next steps?

by European Public Health Alliance | Sep 18, 2020 | Universal Access and Affordable Medicines | Latest Developments

Our organisations, representing patients, consumers, healthcare professionals and public health interests, very much welcome the INI report on the shortage of medicines voted by the European Parliament on September 17th 2020. We remind that shortages of medicines...

“It’s time to invest in a healthy future” EPHA joins calls for more EU support for health in the wake of COVID19

by European Public Health Alliance | Sep 9, 2020 | #EU4Health

The European Public Health Alliance, as part of the EU4Health Civil Society Alliance, has joined calls for the European Commission’s new health programme to be based on 10 guiding principles The coronavirus outbreak has highlighted the inefficiency and inequity of our...

A lost opportunity for the health of Europe

by European Public Health Alliance | Jul 22, 2020 | #EU4Health, COVID-19, EU Budget

The new EU4Health programme, announced in May this year as part of the European Commission’s COVID-19 recovery plan, with proposals to invest in prevention, crisis preparedness, the procurement of vital medicines and equipment to improve health systems and Europeans’...

EPHA joins calls to bring fairer medicine prices to Europe

by European Public Health Alliance | Jul 7, 2020 | Universal Access and Affordable Medicines | Latest Developments

EPHA joins European and international organisations calling on the European Union to bring fairer drug prices in Europe through the use of its legislative and non-legislative instruments, such as the upcoming EU4Health Programme, the European Recovery Instrument and...